$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Chronic pain is officially defined as pain that persists for approximately three months, or for longer than the normal tissue healing time1. This type of pain is one of the main reasons that people are driven to seek medical attention2 and can cost up to $635 billion dollars annually3. Current chronic pain coping strategies are considered archaic; after decades of medical advancements, NSAIDs (nonsteroidal anti-inflammatory drugs) and opioids are still the primary treatments prescribed by physicians. However these treatments target all different types of pain in the same way, providing analgesic effects all over the body as opposed to specifically focusing on the cause of that exact pain incident. In order to better help those suffering from chronic pain, research attention should be shifted towards the etiology and possible pain-specific treatments associated with the most common causes of chronic pain. The goal of this manuscript is to describe a model used to better understand a condition known as Interstitial Cystitis/Painful Bladder Syndrome (IC/BPS).
IC/BPS is a debilitating condition that affects millions of people, primarily women over the age of 40 4. The exact causes of IC/BPS are not known, however prevalence has been linked to genetics5, specific diets, and high stress levels6. Symptoms of IC/BPS include but are not limited to: Increased urgency to urinate, increased frequency of urination, aching, piercing, or burning pain during bladder filling and voiding, and nocturia7. Patients experiencing these conditions have higher stress levels and are more anxious8. This increased stress results in increased pain, which augments the original stress levels. Studies have shown that depression and anxiety levels decrease following treatments that relieve urinary pain, thus effectively breaking this positive-feedback cycle9. One of the challenges in discovering new treatments for IC/BPS has been the paucity of a basic science understanding of bladder pain.
In order to study nervous system contributions to the condition, many animal models have been developed to mimic the pain and symptoms associated with IC/BPS. Traditionally, cystitis has been recreated in animals with the introduction of various chemicals such as mustard oil, acetone, lipopolysaccharide, hydrochloric acid, and cyclophosphamide into the bladder. However no foreign agents are present in the sterile urine of IC/BPS patients, thus questioning the validity of these models. Another murine model of urological pain is urinary bladder distension (UBD)10. In this model, compressed air of a specific pressure is delivered to the bladder of an awake or lightly anesthetized animal over a set period of time. Throughout the procedure, wires in the superior oblique abdominal muscles record electrical activity from the muscle (with an electromyogram (EMG)). This activity is known as the visceromotor response (VMR) and is reliable, reproducible measure of nociception10. Similar hollow organ distention (e.g. bladder, rectum) in healthy human volunteers produces feelings of discomfort and significant increases in reported pain11,12, traits that are often used to diagnose IC/BPS. Thus, in conjunction with electrical, pharmacological, and optogenetic methods of stimulation or inhibition, UBD is a useful and valid model for understanding both the peripheral and central nervous system components of bladder nociception and pain.
Here, we describe the procedure for UBD as is currently used in our laboratory within female members of the common mouse strain, C57Bl/6J. Due to difficulties in the catheterization process of males, this procedure is primarily performed in female mice. This protocol has been adapted from that developed by Ness et al.10 and previously published from our lab13. The following protocol describes four primary components of this model in anesthetized animals: (1) bladder catheter and recording electrode surgery (2) partial anesthesia induction (3) bladder distention and VMR recording, and (4) data analysis of raw VMR/EMG traces. Subtle differences in the UBD-VMR procedure due to choice of organism, anesthesia depth and induction, and body temperature are discussed below.